Related references
Note: Only part of the references are listed.Mendelian randomization study updates the effect of 25-hydroxyvitamin D levels on the risk of multiple sclerosis
Renxi Wang
JOURNAL OF TRANSLATIONAL MEDICINE (2022)
Vitamin D Supplementation Practices among Multiple Sclerosis Patients and Professionals
Weronika Galus et al.
JOURNAL OF CLINICAL MEDICINE (2022)
Vitamin D supplementation in multiple sclerosis: an expert opinion based on the review of current evidence
Robin Boltjes et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2021)
The Impact of Vitamin D Low Doses on Its Serum Level and Cytokine Profile in Multiple Sclerosis Patients
Anna Walawska-Hrycek et al.
JOURNAL OF CLINICAL MEDICINE (2021)
The Effect of Different Administration Time and Dosage of Vitamin D Supplementation in Patients with Multiple Sclerosis: A Meta-Analysis of Randomized Controlled Trials
Xiaofan Yuan et al.
NEUROIMMUNOMODULATION (2021)
Effect of Vitamin D Supplements on Relapse Rate and Expanded Disability Status Scale (EDSS) in Multiple Sclerosis (MS): A Systematic Review and Meta-Analysis
Sara Hanaei et al.
INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE (2021)
Vitamin D status and disability among patients with multiple sclerosis: a systematic review and meta-analysis Running title: Vitamin D status and MS disability
Mahmood Moosazadeh et al.
AIMS NEUROSCIENCE (2021)
Pathophysiological Role and Therapeutic Implications of Vitamin D in Autoimmunity: Focus on Chronic Autoimmune Diseases
Mattia Bellan et al.
NUTRIENTS (2020)
Associations of serum 25(OH) vitamin D levels with clinical and radiological outcomes in multiple sclerosis, a systematic review and meta-analysis
Elena H. Martinez-Lapiscina et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2020)
The 2013 clinical course descriptors for multiple sclerosis A clarification
Fred D. Lublin et al.
NEUROLOGY (2020)
Treatment of Multiple Sclerosis: A Review
Stephen L. Hauser et al.
AMERICAN JOURNAL OF MEDICINE (2020)
Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition
Clare Walton et al.
MULTIPLE SCLEROSIS JOURNAL (2020)
Cholecalciferol in relapsing-remitting MS: A randomized clinical trial (CHOLINE)
William Camu et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2019)
The effects of vitamin D supplementation on expanded disability status scale in people with multiple sclerosis: A critical, systematic review and metaanalysis of randomized controlled trials
Amin Doosti-Irani et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2019)
Vitamin D: Classic and Novel Actions
Angel Gil et al.
ANNALS OF NUTRITION AND METABOLISM (2018)
Lower 25-Hydroxyvitamin D is Associated with Higher Relapse Risk in Patients with Relapsing-Remitting Multiple Sclerosis
C. Wang et al.
JOURNAL OF NUTRITION HEALTH & AGING (2018)
Magnetic Resonance Imaging in Multiple Sclerosis
Christopher C. Hemond et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2018)
The efficacy of vitamin D in multiple sclerosis: A meta-analysis
Zheng Chao et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2018)
Sun Exposure across the Life Course Significantly Modulates Early Multiple Sclerosis Clinical Course
Steve Simpson et al.
FRONTIERS IN NEUROLOGY (2018)
Vitamin D Supplementation Guidelines for General Population and Groups at Risk of Vitamin D Deficiency in Poland - Recommendations of the Polish Society of Pediatric Endocrinology and Diabetes and the Expert Panel With Participation of National Specialist Consultants and Representatives of Scientific Societies-2018 Update
Agnieszka Rusinska et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
Vitamin D for the treatment of multiple sclerosis: a meta-analysis
Laurie McLaughlin et al.
JOURNAL OF NEUROLOGY (2018)
Vitamin D: Nutrient, Hormone, and Immunomodulator
Francesca Sassi et al.
NUTRIENTS (2018)
Vitamin D and Multiple Sclerosis: A Comprehensive Review
Martina B. Sintzel et al.
NEUROLOGY AND THERAPY (2018)
Vitamin D and disability in relapsing-remitting multiple sclerosis in patients with a Mexican background
Yamel Rito et al.
ACTA NEUROLOGICA BELGICA (2018)
The immunological implication of the new vitamin D metabolism
Giulia Bivona et al.
CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY (2018)
Vitamin D and multiple sclerosis: An update
Charles Pierrot-Deseilligny et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2017)
No correlation was observed between vitamin D levels and disability of patients with multiple sclerosis between latitudes 18° and 30° South
Yara Dadalti Fragoso et al.
ARQUIVOS DE NEURO-PSIQUIATRIA (2017)
Safety and immunologic effects of high-vs low-dose cholecalciferol in multiple sclerosis
Elias S. Sotirchos et al.
NEUROLOGY (2016)
Association of seasonal serum 25-hydroxyvitamin D levels with disability and relapses in relapsing-remitting multiple sclerosis
W. Brola et al.
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2016)
Epidemiology of Multiple Sclerosis: From Risk Factors to Prevention-An Update
Alberto Ascherio et al.
SEMINARS IN NEUROLOGY (2016)
Mendelian randomization shows a causal effect of low vitamin D on multiple sclerosis risk
Brooke Rhead et al.
NEUROLOGY-GENETICS (2016)
Vitamin D receptor-retinoid X receptor heterodimer signaling regulates oligodendrocyte progenitor cell differentiation
Alerie Guzman de la Fuente et al.
JOURNAL OF CELL BIOLOGY (2015)
Vitamin D is associated with degree of disability in patients with fully ambulatory relapsing-remitting multiple sclerosis
E. Thouvenot et al.
EUROPEAN JOURNAL OF NEUROLOGY (2015)
Effect of vitamin D on MS activity by disease-modifying therapy class
Dalia L. Rotstein et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2015)
Complementary and Alternative Medicine Use and Nutrient Intake Among Individuals with Multiple Sclerosis in the United States
Laura Masullo et al.
JOURNAL OF COMMUNITY HEALTH (2015)
ATLAS OF MULTIPLE SCLEROSIS 2013: A GROWING GLOBAL PROBLEM WITH WIDESPREAD INEQUITY
Paul Browne et al.
NEUROLOGY (2014)
Vitamin D as an Early Predictor of Multiple Sclerosis Activity and Progression
Alberto Ascherio et al.
JAMA NEUROLOGY (2014)
Preventive effect of vitamin D3 supplementation on conversion of optic neuritis to clinically definite multiple sclerosis: a double blind, randomized, placebo-controlled pilot clinical trial
Hajar Derakhshandi et al.
ACTA NEUROLOGICA BELGICA (2013)
Vitamin D supplementation for patients with multiple sclerosis treated with interferon-beta: a randomized controlled trial assessing the effect on flu-like symptoms and immunomodulatory properties
Daniel Golan et al.
BMC NEUROLOGY (2013)
Practical guidelines for the supplementation of vitamin D and the treatment of deficits in Central Europe - recommended vitamin D intakes in the general population and groups at risk of vitamin D deficiency
Pawel Pludowski et al.
ENDOKRYNOLOGIA POLSKA (2013)
Low vitamin D level is associated with higher relapse rate in natalizumab treated MS patients
T. F. Scott et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2013)
Vitamin D supplementation and monitoring in multiple sclerosis: who, when and wherefore
T. Holmoy et al.
ACTA NEUROLOGICA SCANDINAVICA (2012)
Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis
Ellen M. Mowry et al.
ANNALS OF NEUROLOGY (2012)
A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon β-1b in patients with multiple sclerosis
Merja Soilu-Hanninen et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2012)
Effect of vitamin D3 supplementation on relapses, disease progression, and measures of function in persons with multiple sclerosis: exploratory outcomes from a double-blind randomised controlled trial
Margitta T. Kampman et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Lower serum vitamin D levels are associated with a higher relapse risk in multiple sclerosis
Tessel F. Runia et al.
NEUROLOGY (2012)
Therapeutic Effect of Vitamin D3 in Multiple Sclerosis Patients
Ghasem Mosayebi et al.
IMMUNOLOGICAL INVESTIGATIONS (2011)
A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis
M. S. Stein et al.
NEUROLOGY (2011)
A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis
J. M. Burton et al.
NEUROLOGY (2010)
1,25-dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by inhibiting chemokine synthesis and monocyte trafficking
Laura B. Pedersen et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2007)
Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia
I. A. F. van der Mei et al.
JOURNAL OF NEUROLOGY (2007)
Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis
Kassandra L. Munger et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Vitamin D intake and incidence of multiple sclerosis
KL Munger et al.
NEUROLOGY (2004)
Share Paper
